Clinical Scorecard: Worldwide Rates and Determinants of Depression and Anxiety Among Individuals with Liver Cirrhosis: A Systematic Review and Meta-Analysis

At a Glance

Key Highlights

• Pooled prevalence of depression in cirrhotic patients is 37%.
• Pooled prevalence of anxiety in cirrhotic patients is 53%.
• Age, alcoholism, and viral etiologies are linked to increased depression incidence.
• Depression and anxiety significantly impair quality of life in cirrhosis patients.
• Standardizing screening for depression and anxiety can improve patient outcomes.

Guideline-Based Recommendations

Diagnosis

• Implement standardized screening for depression and anxiety in cirrhosis patients.

Management

• Address psychological burden alongside physical complications in treatment plans.

Monitoring & Follow-up

• Regularly assess mental health status in patients with liver cirrhosis.

Risks

• Increased risk of treatment non-adherence and worsening psychiatric symptoms.

Patient & Prescribing Data

Cirrhotic patients experiencing depression and/or anxiety.

Mental health support is crucial for improving treatment adherence and quality of life.

Clinical Best Practices

• Integrate mental health assessments into routine care for cirrhosis patients.
• Educate patients about the psychological impacts of liver disease.
• Collaborate with mental health professionals for comprehensive care.

References

• Global Burden of Diseases, Injuries, and Risk Factors Study (GBD)